Brian Dorsey, Chief Operating Officer of ARS Pharmaceuticals Inc (SPRY), sold SPRY shares on the open market once in the last 365 days for a total of $190,000. His most recent sale occurred on November 13, 2025. These sales rank 8,519th among 11,678 insiders in our database, where the average is $8.6 million across about six transactions. Dorsey made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 240000 | $0.00 | 240,000.0000 | 98,807,600 | 9999.99% | 0.24% |
| Nov. 13, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Common Stock | 21828 | $0.64 | 32,617.0000 | 98,807,600 | 202.32% | 0.02% |
| Nov. 13, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 21828 | $0.00 | 0.0000 | 98,807,600 | 100.00% | 0.02% |
| Nov. 13, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | S | Common Stock | 21828 | $8.71 | 10,789.0000 | 98,807,600 | 66.92% | 0.02% |
| Jan. 2, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 261900 | $0.00 | 261,900.0000 | 102,390,828 | 9999.99% | 0.26% |
| Dec. 11, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 15000 | $0.00 | 46,828.0000 | 97,032,331 | 24.26% | 0.02% |
| Dec. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 25000 | $0.00 | 21,828.0000 | 97,032,331 | 53.39% | 0.03% |
| Dec. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | S | Common Stock | 25000 | $12.30 | 6,024.0000 | 97,032,331 | 80.58% | 0.03% |
| Dec. 12, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Common Stock | 25000 | $0.64 | 31,024.0000 | 97,032,331 | 415.01% | 0.03% |
| Dec. 11, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | S | Common Stock | 15000 | $12.43 | 6,024.0000 | 97,032,331 | 71.35% | 0.02% |
| Dec. 11, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Common Stock | 15000 | $0.64 | 21,024.0000 | 97,032,331 | 249.00% | 0.02% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | S | Common Stock | 50000 | $15.00 | 6,024.0000 | 95,215,322 | 89.25% | 0.05% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Common Stock | 50000 | $0.64 | 56,024.0000 | 95,215,322 | 830.01% | 0.05% |
| Aug. 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 61,828.0000 | 95,215,322 | 44.71% | 0.05% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Common Stock | 30000 | $0.64 | 36,024.0000 | 95,215,322 | 498.01% | 0.03% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 111,828.0000 | 95,215,322 | 21.15% | 0.03% |
| Aug. 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | S | Common Stock | 30000 | $13.00 | 6,024.0000 | 95,215,322 | 83.28% | 0.03% |
| Jan. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 350000 | $0.00 | 350,000.0000 | 95,215,322 | 9999.99% | 0.37% |
| Jan. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Dorsey Brian | Chief Operating Officer | A | Stock option (right to buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |